FAS and systemic lupus erythematosus: In terms of direct cell-to-cell contact, a prior study reported that systemically injected MSCs could induce T-cell apoptosis via the FAS/FASL pathway in both peripheral blood and bone marrow, leading to immunotolerance in systemic lupus erythematosus animals and humans [12].